TGM4 and prostate cancer: Knockdown of TGM4 by ribozyme transgene reduced adhesion, motility, and invasiveness of CAHPV-10 prostate cancer cells, while forced expression of TGM4 increased adhesion, motility, and invasion of PC-3 prostate cancer cells [270,271,272].